Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Little

Showing results (781-790 of 1,047) with videos related to

Pageof 105
Sort By:
International Journal of Obesity (2005)|February 25, 2023
A randomized controlled trial to reduce post-cessation weight gainKinsey Pebley, Zoran Bursac, Robert C Klesges, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2012
Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitisRuth J Pepper, Dimitrios Chanouzas, Ruth Tarzi, et al.
Experimental and Clinical Psychopharmacology|October 29, 2020
Validity of the alcohol purchase task with United States military personnelKinsey Pebley, James G Murphy, Xin-Qun Wang, et al.
Irish Medical Journal|April 14, 2022
Oro-Naso-Sino-Orbital-Cutaneous Fistula From Prolonged Cocaine UseS Boyle, M Hussain, C Kirby, et al.
Circulation|January 1, 1986
Customary diet, anthropometry, and dyslipoproteinemia in selected North American populations. The Lipid Research Clinics Program Prevalence StudyJ A Little, K Graves, C M Suchindran, et al.
Kidney International Reports|June 2, 2018
Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive HistologyTessa K Novick, Min Chen, Jennifer Scott, et al.
EMBO Reports|October 19, 2001
Mdmx stabilizes p53 and Mdm2 via two distinct mechanismsR Stad, N A Little, D P Xirodimas, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 14, 2001
Practical approach to determining costs and frequency of adverse drug events in a health care networkB L Senst, L E Achusim, R P Genest, et al.
Journal of Cancer Prevention|April 10, 2018
Why Don't Cancer Survivors Quit Smoking? An Evaluation of Readiness for Smoking Cessation in Cancer SurvivorsMelissa A Little, Robert C Klesges, Zoran Bursac, et al.
Alzheimer'S Research & Therapy|July 2, 2020
Community memory screening as a strategy for recruiting older adults into Alzheimer's disease researchGuerry M Peavy, Cecily W Jenkins, Emily A Little, et al.
Pageof 105

Showing results (781-790 of 1,047) with videos related to

Sort By:
Pageof 105
International Journal of Obesity (2005)|February 25, 2023
A randomized controlled trial to reduce post-cessation weight gainKinsey Pebley, Zoran Bursac, Robert C Klesges, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2012
Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitisRuth J Pepper, Dimitrios Chanouzas, Ruth Tarzi, et al.
Experimental and Clinical Psychopharmacology|October 29, 2020
Validity of the alcohol purchase task with United States military personnelKinsey Pebley, James G Murphy, Xin-Qun Wang, et al.
Irish Medical Journal|April 14, 2022
Oro-Naso-Sino-Orbital-Cutaneous Fistula From Prolonged Cocaine UseS Boyle, M Hussain, C Kirby, et al.
Circulation|January 1, 1986
Customary diet, anthropometry, and dyslipoproteinemia in selected North American populations. The Lipid Research Clinics Program Prevalence StudyJ A Little, K Graves, C M Suchindran, et al.
Kidney International Reports|June 2, 2018
Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive HistologyTessa K Novick, Min Chen, Jennifer Scott, et al.
EMBO Reports|October 19, 2001
Mdmx stabilizes p53 and Mdm2 via two distinct mechanismsR Stad, N A Little, D P Xirodimas, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 14, 2001
Practical approach to determining costs and frequency of adverse drug events in a health care networkB L Senst, L E Achusim, R P Genest, et al.
Journal of Cancer Prevention|April 10, 2018
Why Don't Cancer Survivors Quit Smoking? An Evaluation of Readiness for Smoking Cessation in Cancer SurvivorsMelissa A Little, Robert C Klesges, Zoran Bursac, et al.
Alzheimer'S Research & Therapy|July 2, 2020
Community memory screening as a strategy for recruiting older adults into Alzheimer's disease researchGuerry M Peavy, Cecily W Jenkins, Emily A Little, et al.
Pageof 105